Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers.

Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Wong C, Logan J.

Am J Psychiatry. 2001 Mar;158(3):383-9.

PMID:
11229978
2.

Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence.

Wang GJ, Volkow ND, Chang L, Miller E, Sedler M, Hitzemann R, Zhu W, Logan J, Ma Y, Fowler JS.

Am J Psychiatry. 2004 Feb;161(2):242-8.

PMID:
14754772
3.

Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Logan J, Wong C, Miller EN.

Am J Psychiatry. 2001 Mar;158(3):377-82.

PMID:
11229977
4.

Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction.

Volkow ND, Wang GJ, Fowler JS, Hitzemann R, Angrist B, Gatley SJ, Logan J, Ding YS, Pappas N.

Am J Psychiatry. 1999 Jan;156(1):19-26.

PMID:
9892293
5.

Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex.

Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, Logan J, Franceschi D, Gatley J, Hitzemann R, Gifford A, Wong C, Pappas N.

Am J Psychiatry. 2001 Dec;158(12):2015-21.

PMID:
11729018
6.

Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers.

London ED, Simon SL, Berman SM, Mandelkern MA, Lichtman AM, Bramen J, Shinn AK, Miotto K, Learn J, Dong Y, Matochik JA, Kurian V, Newton T, Woods R, Rawson R, Ling W.

Arch Gen Psychiatry. 2004 Jan;61(1):73-84.

PMID:
14706946
7.

Comparison of cerebral glucose metabolism between multiple system atrophy Parkinsonian type and Parkinson's disease.

Feng T, Wang Y, Ouyang Q, Duan Z, Li W, Lu L, Xiang W.

Neurol Res. 2008 May;30(4):377-82. doi: 10.1179/174313208X300396.

PMID:
18544255
8.

Changes in cerebral glucose metabolism during early abstinence from chronic methamphetamine abuse.

Berman SM, Voytek B, Mandelkern MA, Hassid BD, Isaacson A, Monterosso J, Miotto K, Ling W, London ED.

Mol Psychiatry. 2008 Sep;13(9):897-908. Epub 2007 Oct 16.

9.

Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers.

London ED, Berman SM, Voytek B, Simon SL, Mandelkern MA, Monterosso J, Thompson PM, Brody AL, Geaga JA, Hong MS, Hayashi KM, Rawson RA, Ling W.

Biol Psychiatry. 2005 Nov 15;58(10):770-8. Epub 2005 Aug 10.

PMID:
16095568
10.

Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol.

Holcomb HH, Cascella NG, Thaker GK, Medoff DR, Dannals RF, Tamminga CA.

Am J Psychiatry. 1996 Jan;153(1):41-9.

PMID:
8540590
11.

Metabolic changes of subcortical structures in intractable focal epilepsy.

Benedek K, Juhász C, Muzik O, Chugani DC, Chugani HT.

Epilepsia. 2004 Sep;45(9):1100-5.

12.

Dopamine D2 and serotonin S2 receptors in susceptibility to methamphetamine psychosis detected by positron emission tomography.

Iyo M, Nishio M, Itoh T, Fukuda H, Suzuki K, Yamasaki T, Fukui S, Tateno Y.

Psychiatry Res. 1993 Dec;50(4):217-31.

PMID:
8177922
13.

Brain serotonin transporter density and aggression in abstinent methamphetamine abusers.

Sekine Y, Ouchi Y, Takei N, Yoshikawa E, Nakamura K, Futatsubashi M, Okada H, Minabe Y, Suzuki K, Iwata Y, Tsuchiya KJ, Tsukada H, Iyo M, Mori N.

Arch Gen Psychiatry. 2006 Jan;63(1):90-100.

PMID:
16389202
14.

Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism.

Volkow ND, Logan J, Fowler JS, Wang GJ, Gur RC, Wong C, Felder C, Gatley SJ, Ding YS, Hitzemann R, Pappas N.

Am J Psychiatry. 2000 Jan;157(1):75-80.

PMID:
10618016
15.

Decreased dopamine activity predicts relapse in methamphetamine abusers.

Wang GJ, Smith L, Volkow ND, Telang F, Logan J, Tomasi D, Wong CT, Hoffman W, Jayne M, Alia-Klein N, Thanos P, Fowler JS.

Mol Psychiatry. 2012 Sep;17(9):918-25. doi: 10.1038/mp.2011.86. Epub 2011 Jul 12.

16.

Changes in brain glucose metabolism in cocaine dependence and withdrawal.

Volkow ND, Fowler JS, Wolf AP, Hitzemann R, Dewey S, Bendriem B, Alpert R, Hoff A.

Am J Psychiatry. 1991 May;148(5):621-6.

PMID:
2018164
17.

Enhanced sensitivity to benzodiazepines in active cocaine-abusing subjects: a PET study.

Volkow ND, Wang GJ, Fowler JS, Hitzemann R, Gatley SJ, Dewey SS, Pappas N.

Am J Psychiatry. 1998 Feb;155(2):200-6.

PMID:
9464198
18.

Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.

Sekine Y, Iyo M, Ouchi Y, Matsunaga T, Tsukada H, Okada H, Yoshikawa E, Futatsubashi M, Takei N, Mori N.

Am J Psychiatry. 2001 Aug;158(8):1206-14.

PMID:
11481152
20.

Tomographic mapping of human cerebral metabolism: subcortical responses to auditory and visual stimulation.

Mazziotta JC, Phelps ME, Carson RE.

Neurology. 1984 Jun;34(6):825-8.

PMID:
6610136
Items per page

Supplemental Content

Write to the Help Desk